BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38470132)

  • 1. Gene therapy for people with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH; Htet NH; Nikolova D
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013731. PubMed ID: 38837373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer.
    Newhouse R; Nelissen E; El-Shakankery KH; Rogozińska E; Bain E; Veiga S; Morrison J
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD006910. PubMed ID: 37407274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alemtuzumab for multiple sclerosis.
    Riera R; Torloni MR; Martimbianco ALC; Pacheco RL
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD011203. PubMed ID: 37272540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tumour vaccine immunotherapy for the treatment of advanced non-small cell lung cancer: a systematic meta-analysis.
    Wang M; Cao JX; Liu YS; Xu BL; Li D; Zhang XY; Li JL; Liu JL; Wang HB; Wang ZX
    BMJ Open; 2015 Apr; 5(4):e006321. PubMed ID: 25872936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological response in resectable non-small cell lung cancer: a systematic literature review and meta-analysis.
    Waser NA; Quintana M; Schweikert B; Chaft JE; Berry L; Adam A; Vo L; Penrod JR; Fiore J; Berry DA; Goring S
    JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38521542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression-free survival estimation of docetaxel-based second-line treatment for advanced non-small cell lung cancer: a pooled analysis from 18 randomized control trials.
    N C; Jain A; C S; Shreevatsa B; Rajendrasozhan S; Dharmashekar C; Suresh KP; Patil SS; Singh P; Vishwanath P; Srinivasa C; Kollur SP; Shivamallu C
    Front Oncol; 2024; 14():1298786. PubMed ID: 38807763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of Examining Incidentality in Vaccine Safety Assessment.
    Suzumura Y
    Vaccines (Basel); 2024 May; 12(5):. PubMed ID: 38793806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer.
    Nia GE; Nikpayam E; Farrokhi M; Bolhassani A; Meuwissen R
    Mol Ther Oncol; 2024 Mar; 32(1):200788. PubMed ID: 38596310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Vaccines for Follicular Lymphoma: A Systematic Review.
    Suponin A; Zhelnov P; Potanin A; Chekalov A; Lomazov A; Vladimirova K; Lepik K; Muslimov A
    Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma.
    Tomita Y; Moldovan M; Chang Lee R; Hsieh AH; Townsend A; Price T
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012078. PubMed ID: 33210731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.
    Tattersall A; Ryan N; Wiggans AJ; Rogozińska E; Morrison J
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD007929. PubMed ID: 35170751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic vaccines for advanced non-small cell lung cancer.
    Cortés-Jofré M; Rueda-Etxebarria M; Orillard E; Jimenez Tejero E; Rueda JR
    Cochrane Database Syst Rev; 2024 Mar; 3(3):CD013377. PubMed ID: 38470132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis inhibitors for the treatment of epithelial ovarian cancer.
    Gaitskell K; Rogozińska E; Platt S; Chen Y; Abd El Aziz M; Tattersall A; Morrison J
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD007930. PubMed ID: 37185961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.